AMERICAN REBEL HOLDINGS INC (AREB)

US02919L3078 - Common Stock

2.52  -0.17 (-6.32%)

After market: 2.55 +0.03 (+1.19%)

Fundamental Rating

1

AREB gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 84 industry peers in the Commercial Services & Supplies industry. AREB has a bad profitability rating. Also its financial health evaluation is rather negative. AREB is valued expensive and it does not seem to be growing.



0

1. Profitability

1.1 Basic Checks

AREB had negative earnings in the past year.
In the past year AREB has reported a negative cash flow from operations.
In the past 5 years AREB always reported negative net income.
AREB had a negative operating cash flow in each of the past 5 years.

1.2 Ratios

The Return On Assets of AREB (-138.55%) is worse than 97.62% of its industry peers.
Looking at the Return On Equity, with a value of -723.82%, AREB is doing worse than 91.67% of the companies in the same industry.
Industry RankSector Rank
ROA -138.55%
ROE -723.82%
ROIC N/A
ROA(3y)-249.25%
ROA(5y)-337.62%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

The Gross Margin of AREB (10.42%) is worse than 84.52% of its industry peers.
AREB's Gross Margin has declined in the last couple of years.
AREB does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 10.42%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-7.72%
GM growth 5Y-21.19%

0

2. Health

2.1 Basic Checks

AREB does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, AREB has more shares outstanding
AREB has more shares outstanding than it did 5 years ago.
AREB has a worse debt/assets ratio than last year.

2.2 Solvency

Based on the Altman-Z score of -7.49, we must say that AREB is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of AREB (-7.49) is worse than 94.05% of its industry peers.
A Debt/Equity ratio of 2.57 is on the high side and indicates that AREB has dependencies on debt financing.
AREB has a worse Debt to Equity ratio (2.57) than 83.33% of its industry peers.
Industry RankSector Rank
Debt/Equity 2.57
Debt/FCF N/A
Altman-Z -7.49
ROIC/WACCN/A
WACC12.61%

2.3 Liquidity

A Current Ratio of 0.93 indicates that AREB may have some problems paying its short term obligations.
AREB has a worse Current ratio (0.93) than 82.14% of its industry peers.
AREB has a Quick Ratio of 0.93. This is a bad value and indicates that AREB is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.28, AREB is doing worse than 95.24% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.93
Quick Ratio 0.28

2

3. Growth

3.1 Past

AREB shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -69.60%.
The Revenue has decreased by -3.53% in the past year.
Measured over the past years, AREB shows a very strong growth in Revenue. The Revenue has been growing by 162.58% on average per year.
EPS 1Y (TTM)-69.6%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-824.2%
Revenue 1Y (TTM)-3.53%
Revenue growth 3Y134.41%
Revenue growth 5Y162.58%
Sales Q2Q%-11.3%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y266.67%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year21.58%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for AREB. In the last year negative earnings were reported.
The Price/Forward Earnings ratio is 22.46, which indicates a rather expensive current valuation of AREB.
Compared to the rest of the industry, the Price/Forward Earnings ratio of AREB indicates a somewhat cheap valuation: AREB is cheaper than 67.86% of the companies listed in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 23.40. AREB is around the same levels.
Industry RankSector Rank
PE N/A
Fwd PE 22.46

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for AREB!.
Industry RankSector Rank
Dividend Yield N/A

AMERICAN REBEL HOLDINGS INC

NASDAQ:AREB (11/15/2024, 8:00:00 PM)

After market: 2.55 +0.03 (+1.19%)

2.52

-0.17 (-6.32%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryCommercial Services & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap2.72M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 22.46
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -138.55%
ROE -723.82%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM 10.42%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover1.17
Health
Industry RankSector Rank
Debt/Equity 2.57
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 0.93
Quick Ratio 0.28
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)-69.6%
EPS 3YN/A
EPS 5Y
EPS Q2Q%
EPS Next Y266.67%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-3.53%
Revenue growth 3Y134.41%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y